Home › Funds › Millennium Management › CBIO
Millennium Management position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
Latest position (Q2 2026)403.86K sh
Reported value held$7.27M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 671.22K | $2.76M | New |
| Q4 2021 | 909.24K | $831.00K | Add |
| Q1 2022 | 637.80K | $421.00K | Reduce |
| Q2 2022 | 337.33K | $600.00K | Reduce |
| Q3 2022 | 894.72K | $451.00K | Add |
| Q4 2022 | 195.02K | $103 | Reduce |
| Q1 2023 | 272.31K | $56 | Add |
| Q4 2025 | 61.88K | $733.92K | New |
| Q1 2026 | 323.55K | $5.94M | Add |
| Q2 2026 | 403.86K | $7.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CBIO
- Fidelity Management & Research (FMR) 4.13M sh · $74.40M · Q2 2026
- Balyasny Asset Management 1.66M sh · $29.93M · Q2 2026
- BlackRock Inc 1.27M sh · $22.89M · Q2 2026
- Geode Capital Management 384.58K sh · $6.92M · Q2 2026
- Vanguard Group 557.51K sh · $6.61M · Q4 2025
- Point72 Asset Management 300.00K sh · $5.40M · Q2 2026
- Marshall Wace 214.30K sh · $3.86M · Q2 2026
- Two Sigma Investments 186.87K sh · $3.36M · Q2 2026
- UBS Group AG 175.18K sh · $3.15M · Q2 2026
- Northern Trust Corp 138.78K sh · $2.50M · Q2 2026
- Charles Schwab Investment Management 50.26K sh · $904.64K · Q2 2026